Moss Introduces New Gut Microbiome Test
Vancouver, British Columbia--(Newsfile Corp. - March 28, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia, announces the introduction of its Gut Microbiome test which can be ordered directly to your home via the Company's online platform. The gut microbiome is home to trillions of microbes that directly influence a person's mood, how they digest food and how their immune system responds to...
2023-03-28 8:30 AM EDT
Moss Announces Grant of Incentive Stock Options
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia, announces that the Company has granted incentive stock options to certain directors, officers and consultants to acquire 1,320,000 common shares of the Company at a price of C$0.10 per share, vesting immediately. Moss has created an online healthcare and technology platform integrating...
2023-02-27 7:30 PM EST
Moss to Commence Trading on the Canadian Securities Exchange on January 19, 2023
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia, is pleased to announce that its common shares have been approved for listing on the Canadian Securities Exchange (the "CSE") and will commence trading at market open on Thursday, January 19, 2023 under the stock ticker symbol "MOSS". Moss provides comprehensive and affordable, at-home...
2023-01-18 7:55 PM EST